Behind the scenes, McKinsey led companies at the center of the opioid crisis
In 2017, less than two years later, the FDA took the rare step of requiring Endo to withdraw Opana from the market, citing the serious… Read More »Behind the scenes, McKinsey led companies at the center of the opioid crisis